BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory…
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory…
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics.…
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients…
Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent…
European companies must be able to provide developed and scalable business models if they want to enter the US to…
A £29bn investment into the National Health System (NHS) is ‘substantial’, but reform of the system is essential to ‘fix…
MSD’s investigational KRAS G12C inhibitor has shown signs of anti-tumour activity when used both alone and in combination with other oncology…
Merck KGaA (Merck) is filing for global regulatory approvals of its CSF-1R inhibitor pimicotinib after it met the primary and all…
As the pharma industry navigates uncertainty caused by successive moves by the US administration, including international tariffs and drug pricing…
Apnimed’s oral sleep apnoea therapy AD109 has met the primary endpoint in a Phase III trial, with hopes to file…